NetworkNewsBreaks

TuesdaySep 07, 2021 9:33 am

NetworkNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Ownership Increase in Subsidiary Holding

AnPac Bio-Medical Science (NASDAQ: ANPC) subsidiary AnPac Bio-Medical Science (Lishui) Co. Ltd. has increased its holding in AnPai (Shanghai) Healthcare Management Consultant Co. Ltd., one of its subsidiaries; the increase came after approval was granted by the company audit committee and board of directors. The company announced that in late August 2021 it finalized the share structure registration amendment with the local Administration Management Bureau. Before making the decision, company officials conducted rigorous due diligence that included obtaining financial and legal audits and appraisals by a qualified appraiser. AnPac Bio-Medical Science is a biotechnology company with operations in China and…

Continue Reading

FridaySep 03, 2021 2:50 pm

NetworkNewsBreaks – InnerScope Hearing Technologies Inc. (INND) to Be Featured in ‘New to the Street’ Broadcast

InnerScope Hearing Technologies (OTC: INND) will be featured in an upcoming segment of FMW Media’s “New to the Street” nationally syndicated show. The company will be one of eight featured on Sunday, Sept. 5, 2021, with the broadcast airing at 10 to 11 a.m. ET. The segment will include an interview with INND CEO Matthew Moore, who will inform viewers about the company’s emerging and disruptive leadership in the direct-to-consumer (“DTC”) hearing technology space. Moore will discuss INND’s successful direct-marketing strategy, helping to get the company’s hearing aids, selling at a fraction of the cost of products offered by major…

Continue Reading

FridaySep 03, 2021 1:54 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Proprietary Technology Elevating Quantity of Drugs Delivered Across Blood-Brain Barrier by 1,900%

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced that a tolerability and pharmacokinetic study, performed by an independent, premier animal testing laboratory in the U.S., had demonstrated that administration of colchicine using its proprietary DehydraTECH(TM) resulted in increased delivery. “Colchicine is an approved therapeutic with anti-inflammatory effects primarily used to treat gout and cardiac conditions such as pericarditis. It was the latest of several drugs Lexaria tested with known SARS-CoV-2/COVID-19 antiviral properties after it showed potent effects in mitigating the cytokine storm associated with the virus. Additionally, colchicine is occasionally used to treat emergent pericarditis in children, which would make the…

Continue Reading

FridaySep 03, 2021 1:39 pm

NetworkNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Subsidiary Supplying Bottled Water to BC Firefighters Sourced from the Very Land They Protect

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced that its wholly owned subsidiary Naturo Group had been selected to manufacture and supply a special, limited-edition run of its TRACE-branded, alkaline spring water to the BC Wildfire Services, which employs 1,100 Type 1 firefighters. BevCanna president Melise Panetta is quoted in a recent article as saying, “We are proud to be providing the firefighters with a special edition of our TRACE-branded natural 7.7pH alkaline spring water, sourced directly from our proprietary BC interior aquifer – the very land and…

Continue Reading

FridaySep 03, 2021 1:27 pm

NetworkNewsBreaks – FingerMotion Inc. (FNGR) on Path to Complete Insurtech Model by YE 2021

FingerMotion (OTCQX: FNGR) is an evolving technology company with three operational and revenue-generating business units – TPS, SMS & MMS, and Big Data – with plans to make a fourth division, the rich communication services (“RCS”), operational in due course. “Earlier this year, buoyed by its big data product dubbed Sapientus, the company forayed into insurtech through its partnership with Pacific Life Re-insurance, which appears to have set the foundation for similar alliances in the sector,” reads a recent article. “Since then, FNGR has entered into an agreement with Happy Life Insurance to create an innovative, data-driven insurance business model…

Continue Reading

FridaySep 03, 2021 12:12 pm

NetworkNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) Helping Companies Build Long-Term Customer Relationships

Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, recently announced the launch of its call center. “The WeChat call center is designed to help businesses build an automated and personalized private domain traffic operation platform that will help the B2C clients achieve major upgrades while drawing on the advantages of the powerful WeChat ecosystem for interacting with customers,” reads a recent article. Companies seeking to use their resources in the most effective manner possible to acquire and retain consumers have turned to Infobird, which, through the WeChat call center and other technologies, is facilitating just that. “Using…

Continue Reading

FridaySep 03, 2021 12:00 pm

NetworkNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Featured in Article as Stock That Is ‘Shaping up to Be a Brilliant Investment’

Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company focused on advancing psychedelic pharmaceutical therapeutics for various psychiatric and neurological conditions, was highlighted in a Motley Fool article titled, “Buying Cybin Stock Right Now Could Be a Brilliant Move.” The piece, written by Alex Carchidi, delves into CYBN as one of those investment opportunities in places outside the mainstream. “Cybin (NYSE: CYBN) is a biotech that's developing mental illness treatments derived from widely illegal psychedelic chemicals like psilocybin (best known as the active compound in ‘magic mushrooms’). Based on a swath of extremely positive coverage in the scientific literature,…

Continue Reading

FridaySep 03, 2021 11:55 am

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at Cannabis Investor Conference

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol ("CBN"), will be a featured company in the upcoming Cannabis Industry Virtual Investor Conference, slated for Sept. 8–9, 2021; INM’s presentation is scheduled for Sept. 8 at 1:30 p.m. ET. The two-day conference is an exclusive opportunity for cannabis company leaders to share the vision and mission of their companies and meet with potential investors.The conference is hosted by Virtual Investor Conferences (“VIC”) in partnership with KCSA Strategic Communications. VIC is part of OTC Market Group’s…

Continue Reading

FridaySep 03, 2021 10:25 am

NetworkNewsBreaks – Culp, Inc. (NYSE: CULP) Featured in Earnings Release Research from Sidoti

Expect Solid Growth from Infrastructure Leverage and Continued Favorable Demand Culp (NYSE: CULP) was featured in a company-sponsored research earnings release note published by Sidoti & Company, LLC. The report reads, “With increased demand in both operating segments (mattress fabrics and upholstery fabrics), CULP expects F2022 revenue growth of 8% to 12%, which is better than the approximate 7% revenue increase expected by consensus.” To access the full report, visit https://nnw.fm/NW8sI About Culp, Inc. Culp is one of the world’s largest marketers of mattress fabrics for bedding and upholstery fabrics for residential and commercial furniture. The company markets a variety…

Continue Reading

FridaySep 03, 2021 10:13 am

NetworkNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Receipt of GMC Authorization Permitting Cosmetic Product Manufacturing

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced that it has received Good Manufacturing Practices (“GMP”) certification from the Colombian National Food and Drug Surveillance Institute (“INVIMA”) authorizing the manufacture of cosmetics products. Effective immediately, the authorization allows Flora to offer cosmetic products for export to international markets that require goods meet the rigorous GMP standards. The authorization also recognizes the Flora lab for its quality procedures, which are in line with global pharmaceutical companies, and demonstrates the company’s operational excellence and capability of achieving pharmaceutical-grade standards. Those standards are recognized…

Continue Reading